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DObjectives: Restrictive mitral valve annuloplasty combined with coronary artery bypass grafting is the
treatment of choice for ischemic mitral regurgitation. Postoperative functional mitral stenosis and its potential
impact on functional capacity remain the object of debate. The aim of this study was to assess functional and
hemodynamic outcome at rest and during exercise in a population with ischemic mitral regurgitation after a
standardized restrictive mitral valve annuloplasty.
Methods: A total of 23 patients with ischemic mitral regurgitation who were previously treated with coronary
artery bypass grafting and restrictive mitral valve annuloplasty underwent a semi-supine (bicycle) exercise test
with Doppler echocardiography and ergospirometry. The surgical technique was identical in all patients, using a
complete semi-rigid ring downsized by 2 sizes after measuring the height of the anterior mitral leaflet, to achieve
a coaptation length of at least 8 mm.
Results: At a mean follow-up of 28 15 months, mean transmitral gradients at rest and maximal exercise were
4.4  1.8 mm Hg and 8.2  4.2 mm Hg, respectively (P<.001). Transmitral gradients did not correlate with
exercise capacity (maximal oxygen uptake) or pulmonary artery pressures. Patients with a resting mean gradient
of 5 mmHg or greater (n¼ 9) reached a significantly higher maximal oxygen uptake; however, they had a better
ejection fraction and cardiac output at rest and reached a higher cardiac output at peak exercise.
Conclusions: Transmitral gradients after restrictive mitral valve annuloplasty for ischemic mitral regurgitation
did not correlate with functional capacity as measured by maximal oxygen uptake during semi-supine bicycle
testing. Functional capacity and transmitral gradients are determined not only by the severity of mitral stenosis
but also by hemodynamic factors, such as ejection fraction and cardiac output. Transmitral gradients should be
interpreted with respect to patient hemodynamics and not necessarily be considered as detrimental for functional
capacity. (J Thorac Cardiovasc Surg 2014;148:183-7)Restrictive mitral valve annuloplasty (RMA) has become
the preferred surgical approach in the management of
ischemic mitral regurgitation (IMR) on the basis of good
short- and mid-term data from observational studies.1-3
RMA involves the insertion of an undersized prosthetice Department of Cardiology,a Ziekenhuis Oost-Limburg, Genk, Belgium;
ty of Medicine and Life Sciences,b Hasselt University, Diepenbeek, Belgium;
epartment of Cardiovascular Surgery,c Ziekenhuis Oost-Limburg, Genk,
um.
rand is supported by a grant of the Research Foundation Flanders (FWO,
214N). Drs Bertrand and Vandervoort are researchers for the Limburg
cal Research Program UHasselt-ZOL-Jessa, supported by the foundation
urg Sterk Merk, Hasselt University, Ziekenhuis Oost-Limburg, and Jessa
ital.
ures: Dr Dion received consulting fees from Edwards Lifesciences, Johnson &
on, Sorin, Medtronic, and St Jude Medical. All other authors have nothing to
se with regard to commercial support.
d at The 2013 American Association for Thoracic Surgery Mitral Conclare;
York, New York, May 2, 2013.
d for publication April 25, 2013; revisions received Aug 28, 2013; accepted
blication Oct 6, 2013; available ahead of print Dec 10, 2013.
for reprints: Philippe B. Bertrand, MD, MSc, Department of Cardiology,
nhuis Oost-Limburg, Schiepse Bos 6, 3600 Genk, Belgium, Europe
ail: philippe.bertrand@zol.be).
23/$36.00
ht  2014 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2013.10.013
The Journal of Thoracic and Caring, thereby reducing anteroposterior dimensions of the
mitral annulus, resulting in improved leaflet coaptation.
At mid-term follow-up, this procedure has been shown to
induce significant reverse remodeling and improve systolic
function, making it an effective strategy for patients with
severe IMR.3 However, several recent studies have
demonstrated the occurrence of moderate ‘‘functional’’
mitral stenosis (MS) after RMA, that is, a mean transmitral
pressure gradient greater than 5 mm Hg or a mitral valve
area less than 1.5 cm2, with incidences of MS ranging
from 9%4 to 54%5 after RMA. The impact of a postopera-
tive MS on functional and clinical outcome remains
controversial. Magne and colleagues6 demonstrated a
significant negative correlation between mitral peak
gradient at rest and 6-minute walking test distance, suggest-
ing a deleterious effect on functional capacity. Other studies
have failed to demonstrate an effect of transmitral gradients
on survival,5,7,8 adverse cardiac events,4 or New York Heart
Association functional class.7 In many of those patient
groups, operative techniques and surgical end points of
RMA were heterogeneous and nonstandardized. The aim
of the current study was to assess functional capacity and
hemodynamic outcome in a homogeneous populationrdiovascular Surgery c Volume 148, Number 1 183
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
ICU ¼ intensive care unit
IMR ¼ ischemic mitral regurgitation
IQR ¼ interquartile range
LV ¼ left ventricular
MR ¼ mitral regurgitation
MS ¼ mitral stenosis
PAP ¼ pulmonary artery pressure
RMA ¼ restrictive mitral valve annuloplasty
VO2max ¼ maximal oxygen uptake
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operative coaptation length of at least 8 mm.MATERIALS AND METHODS
Study Population
Between July 2007 and August 2012, 52 standardized RMA procedures
in patients with IMR have been performed in our center. These procedures
comprised all urgent (within 72 hours of admission), semi-urgent
(within 14 days during the same hospital stay), and elective procedures.
At 39  15 months postoperatively, all survivors (n ¼ 34) were contacted
to undergo a resting echocardiography followed by an exercise stress
echocardiography with ergospirometry, as approved by the local ethics
committee. Written informed consent was obtained from all of the
participating patients. Figure 1 displays the study flow chart, with 11
patients refusing participation for various reasons. The final study
population consisted of 23 patients with IMR who were previously treated
with coronary artery bypass grafting (CABG) and standardized RMA and
who underwent a single study visit at our center with resting and exercise
echocardiography.
Surgical Procedure
All surgical procedures were performed through a midline sternotomy
under normothermic cardiopulmonary bypass with intermittent antegrade
warm blood cardioplegia. After the revascularization procedure, the mitral
valve was exposed through a vertical trans-septal approach. Mitral
annuloplasty ring size was determined after careful measurement of the
height of the anterior leaflet and downsized by 2 sizes with a complete
semi-rigid annuloplasty ring (Carpentier-Edwards Physio Ring I; Edwards
Lifesciences, Irvine, Calif). A saline test was performed to check the
symmetric and posteriorly located line of coaptation. After weaning from
cardiopulmonary bypass, intraoperative transesophageal echocardiography
was used to assess the result and to measure leaflet coaptation. A minimum
coaptation length of 8 mm in the A2-P2 segment was pursued.
Transthoracic Echocardiography
Preoperative 2-dimensional echocardiography examinations were
retrospectively analyzed for comparison with the echocardiographic data at
the follow-up visit. The postoperative mean transmitral gradient from all
patients (also patients not participating in the exercise echocardiography)
was retrospectively measured from 2-dimensional echocardiography, which
was systematically performed immediately after intensive care unit (ICU)
discharge. All echocardiographic examinations were performed with a
commercially available system (IE33; Philips Healthcare, Andover, Mass)
and with standard 2-dimensional and Doppler echocardiographic images
acquired in the left lateral decubitus position using a phased-array transducer
in the parasternal and apical views by experienced cardiac sonographers.184 The Journal of Thoracic and Cardiovascular SurgAt the study visit, 3 consecutive cardiac cycles were recorded and stored
for subsequent offline analysis. Left ventricular (LV) end-diastolic and
end-systolic dimensions were measured from parasternal acquisitions. LV
volumes and ejection fraction were calculated using the modified Simpson’s
biplanemethod. LV stroke volumewasmeasured by pulsed-wave Doppler in
the LVoutflow tract. Color flow was applied in the apical 4-chamber view to
assess the severity ofmitral regurgitation (MR),whichwasgradedby thevena
contracta width. Peak and mean transmitral gradients were calculated using
the modified Bernoulli equation on the continuous-wave signal. Systolic
pulmonary artery pressure (PAP) was calculated using the modified
Bernoulli equation on the transtricuspid continuous-wave Doppler signal,
while adding right atrial pressure.9
Exercise Protocol
All 23 patients underwent a symptom-limited graded bicycle test in a
semi-supine position on a tilting exercise table. Workload was initiated
at 20 Watts, with increments of 20 Watts every 3 minutes. In patients
with poor general condition, an adjusted protocol was appliedwith 10Watts
of initial workload and increments of 10 Watts every 3 minutes.
Blood pressure and a 12-lead electrocardiogram were recorded at each
stage. Two-dimensional and Doppler echocardiographic recordings were
made at each stage, that is, for measuring LV geometry and function,
LV stroke volume, MR vena contracta width, peak and mean transmitral
gradient, and systolic PAP.
Cardiopulmonary Exercise Testing
Real-time ergospirometry data were assessed using a commercially
available system (JAEGER, W€urzburg, Germany). Maximal oxygen
uptake (VO2max) during exercise was assessed in all patients.
Statistical Analysis
Results are expressed as mean  standard deviation if normally
distributed or otherwise by median and interquartile range (IQR).
Normality was assessed by the Shapiro–Wilk statistic. The paired Student
t test and Wilcoxon signed-rank test were used when appropriate to
compare between preoperative and postoperative echocardiographic
parameters and between resting and exercise data in the postoperative
setting. Categoric values were compared using the Pearson chi-square
test when appropriate. Cumulative survival curves were calculated
according to the Kaplan–Meier method, and survival in high versus low
gradient groups was compared with the log-rank test. Statistical
significance was set at a 2-tailed probability of P<.05. Statistical analyses
were performed using the Statistical Package for Social Sciences release
20.0 (SPSS Inc, Chicago, Ill).
RESULTS
Preoperative and Operative Clinical Data
Preoperative patient characteristics are summarized in
Table 1. The patient population consisted of 23 patients
with IMR, with a median ring size of 26 (IQR, 26-28) and
a median postoperative coaptation length of 8.8 mm
(IQR, 7.6-9.0 mm). In 3 of 23 patients (12%), a
concomitant aneurysmectomy was performed, and 3 of
23 patients (12%) received a cardiac resynchronization
therapy device before our study follow-up examination.
Comparison of Preoperative Versus Postoperative
(Follow-up) Echocardiography
At a mean follow-up of 28  15 months, in the group
of 17 patients without aneurysmectomy and cardiacery c July 2014
TABLE 1. Preoperative patient characteristics
Variables Patients with IMR (n ¼ 23)
Age at surgery, y 65  10
Male gender 18 (78%)
Body surface area, m2 1.92  0.16
NYHA class, I/II/III/IV 1/8/11/3
Cardiovascular risk factors
Diabetes 9 (39%)
Hypertension 14 (61%)
Obesity 7 (30%)
Smoking habits 13 (57%)
Hyperlipidemia 16 (70%)
Familial history of ischemia 7 (30%)
Baseline medication
ACEI/ARB 17 (74%)
Beta-blockers 21 (91%)
Loop diuretics 15 (65%)
Statins 19 (83%)
Anticoagulation 4 (17%)
Antiplatelet therapy 22 (96%)
Comorbidity
CKD 6 (26%)
COPD 6 (26%)
Prior PCI 7 (30%)
Operative data
Cardiopulmonary bypass time, min 212  51
Aortic crossclamp time, min 158  45
Coaptation length postoperatively, mm 8.8 (IQR 7.6-9.0)
þ concomitant TVP 10 (43%)
þ LV aneurysmectomy 3 (12%)
þ AVR (bioprosthesis) 1 (4%)
ACEI, Angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker;
AVR, aortic valve replacement; CKD, chronic kidney disease; COPD, chronic
obstructive pulmonary disease; IMR, ischemic mitral regurgitation; LV, left
ventricular; NYHA, New York Heart Association; PCI, percutaneous coronary
intervention; TVP, tricuspid valve annuloplasty.
FIGURE 1. Study flow chart. MR, Mitral regurgitation.
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Dresynchronization therapy device implantation, there was a
decrease in LV end-diastolic volume and end-systolic
volume compared with the preoperative setting (preopera-
tive 141  52 mL and 86  44 mL vs postoperative
113  44 mL and 62  37 mL, P ¼ .035 and P ¼ .052,
respectively) and a nonsignificant increase in ejection
fraction (38%  11% vs 45%  15%, P ¼ .095). In all
23 study patients, MR jet vena contracta width significantly
decreased (3.8  1.8 mm vs 1.3  1.0 mm, P<.001), with
more than moderate recurrent MR (ie, vena contracta width
>3 mm, but<5 mm) in 1 patient (4%). There was a nonsig-
nificant decrease in systolic PAP (50  8 vs 45  14,
P ¼ .093) compared with preoperatively.
Exercise Hemodynamics
Resting and exercise hemodynamics in the study group
are displayed in Table 2. Resting mean and peak transmitral
gradients were 4.4  1.8 mm Hg and 11.4  3.6 mm Hg,
respectively, with a mean gradient of 5 mm Hg or greater
in 9 patients (39%). There was a significant increase in
transmitral mean and peak gradient with exercise, along
with a significant increase in systolic PAP and cardiac
output. Exercise systolic PAP was not correlated with
transmitral mean or peak gradients during exercise
(r ¼ 0.068, P ¼ .77 and r ¼ 0.258, P ¼ .26, respectively).
Functional Capacity
Full ergospirometry data were available in 22 patients,
and 1 patient refused the ergospirometry mask. There
was no correlation between VO2max and peak or mean
transmitral gradients at rest, with r ¼ 0.271, P ¼ .223 andThe Journal of Thoracic and Car ¼ 0.181, P< .421, respectively. Patients with a resting
mean transmitral gradient of 5 mm Hg or greater (n ¼ 9)
had significantly higher exercise capacity, higher VO2max,
and higher cardiac output both at rest and during maximal
exercise compared with patients with less than 5 mm Hg
resting mean transmitral gradient (n ¼ 14) (Table 2).Impact on Survival
In 42 patients with IMR with echocardiography data
available at median of 7 days (IQR, 6-11) after surgery
(shortly after ICU discharge), the mean transmitral gradient
was 4.7  1.6 mm Hg. When dichotomizing into patients
with a mean gradient 5 mm Hg or greater (n ¼ 22) versus
less than 5 mm Hg (n ¼ 20), there was no difference in
the (late) survival rate (log-rank P ¼ .92, Figure 2).DISCUSSION
RMA combined with CABG has been proposed as the
procedure of choice for the management of IMR. Severalrdiovascular Surgery c Volume 148, Number 1 185
TABLE 2. Comparison of postoperative parameters in resting condition and during exercise
Variables
Total population
Mean gradient
<5 mm Hg (n ¼ 14)
Mean gradient
5 mm Hg (n ¼ 9) P value
Resting Exercise
P
value Resting Exercise
P
value Resting Exercise
P
value Resting Exercise
LV ejection fraction,% 46  14 42  16 53  7 .036
LV EDV, mL 125  10 138  55 105  30 .076
LV ESV, mL 72  9 86  49 50  15 .020
LV EDD, mm 54  2 57  8 50  7 .033
LV ESD, mm 45  2 48  10 41  7 .064
Decrease LV EDV,y% 26 (46) 26 (43) 19 (49) .91
NYHA class I/II/III/IV 10/11/2/0 5/7/2/0 5/4/0/0 .40
Physio Ring (Edwards
Lifesciences, Irvine, Calif)
size 24/26/28/30/32
3/9/7/2/2 2/3/5/2/2 1/6/2/0/0 .21
Maximal workload, Watt 50  23 38  14 69  23 <.001
VO2max, mL/kg/min 13.5  3.4 12.3  3.4 15.3  2.6 .035
MV peak gradient, mm Hg 11.4  3.6 16.8  6.1 <.001 9.5  2.7 13.1  4.3 .004 14.5  2.6 22.6  3.4 .001 <.001 <.001
MV mean gradient, mm Hg 4.4  1.8 8.2  4.2 <.001 3.3  1 5.7  1.6 <.001 6.2  1 12.0  4.0 .003 <.001 <.001
Systolic PAP, mm Hg* 43  13 53  20 <.012 43  15 46  26 .105 43  11 50  20 .05y .94 .71
Cardiac output 3.9  0.8 5.8  2.0 <.001 3.6  0.8 4.7  1.3 .01 4.4  0.8 7.3  2.0 .001 .03 .001
Cardiac Index 2.1  0.4 3.0  0.9 <.001 1.9  0.4 2.5  0.7 .001 2.3  0.4 3.7  0.9 .001 .09 .002
MRVC width, mm 1.3  1.0 1.3  1.2 NS 1.2  1.2 1.2  1.2 NS 1.4  0.7 1.3  1.3 NS NS NS
Bold values indicate a level of significance<.05. EDD, End-diastolic diameter; EDV, end-diastolic volume; ESD, end-systolic diameter; ESV, end-systolic volume; LV, left
ventricle;MRVC,mitral regurgitation vena contracta;MV,mitral valve;NS, not significant;NYHA,NewYork Heart Association; PAP, pulmonary artery pressure. *Paired samples
only: n ¼ 20 in total population, n ¼ 12 in low gradient group, n ¼ 8 in high gradient group. yMeasured as preoperative LV EDV minus postoperative LV EDV, divided by pre-
operative LV EDV; expressed as median (IQR).
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iatrogenic MS, with the cause of stenosis due to a too
stringent ring selection6 or ongoing diastolic leaflet
tethering.10 The functional impact of this MS remainsFIGURE 2. Impact of postoperative gradient on late mortality:
Kaplan–Meier survival curves according to the mean transmitral gradient
at ICU discharge.
186 The Journal of Thoracic and Cardiovascular Surgdebated, with one study showing a deleterious effect of
this stenosis on functional capacity,6 whereas other series
could find no impact on New York Heart Association class7
or clinical outcome.4,5,8 In many of those patient
groups, operative techniques and surgical end points were
heterogeneous and nonstandardized.
In this study, all patients underwent a standardized
2-size-under RMA for IMR using a complete semi-rigid
(Physio Ring I) annuloplasty ring. Our results confirm the
positive effect of RMA on LV remodeling and low
recurrence of significant MR. Overall peak and mean
transvalvular gradients at rest are mildly elevated and in
line with previously published data. At a mean follow-up
of 28  15 months, a moderate functional MS (mean
transmitral gradient 5 mm Hg) was present in 39% of
patients; however, we did not see an effect on functional
capacity, measured by VO2max. This is in contrast with
previous findings6 showing a strong negative correlation
between resting transmitral gradients and exercise capacity
as measured by a 6-minute walking test. Because the
transmitral gradient is a flow-dependent variable, our
findings possibly reflect the fact that in patients with a
higher cardiac output a higher gradient will be observed
over a comparable degree of stenosis. Indeed, ejection
fraction and cardiac output at rest were significantly higher
in our patients with gradients of 5 mm Hg or greater, which
could explain the higher gradients in this patient group
without negative impact on functional capacity. Theseery c July 2014
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Dfindings are in accordance with recent observations of Ru-
bino and colleagues7 and Williams and colleagues,5 both
showing better postoperative remodeling in patients with
a baseline gradient 5 mm Hg or greater. It is important to
keep in mind that the transmitral gradient depends on
both intrinsic stenosis and transmitral flow, and therefore
should always be interpreted with respect to cardiac output.
As such, an increased transmitral gradient post-RMA in a
patient with normal ejection fraction and cardiac output
may be acceptable and have no impact on functional
capacity, whereas a ‘‘normal’’ transmitral gradient in a
patient with poor LV function may mask significant MS.
In the future, a more flow-independent parameter, such as
mitral valve area, should be validated to use in the
assessment of functional MS in patients with RMA.
In functional MR surgery, the surgical end point should
be to achieve an optimal coaptation length. Previous studies
have shown that a length of 8 mm in A2-P2 can offer a
durable result with only minor MR recurrence.3 In the
present study, in the homogeneous population with IMR
with structurally normal mitral leaflets, undersizing by 2
sizes using the Physio I ring was needed to obtain that
particular end point. However, it should be noted that in
patients with the presence of leaflet calcifications or
sclerotic alterations (ie, in concomitant rheumatic valve
disease), undersizing must be lessened (1 size) or even
avoided with or without leaflet augmentation to obtain
the 8-mm coaptation endpoint. When annuloplasty is
impossible because of heavy annular calcifications, leaflet
augmentation by means of autologous pericardium must
be considered instead.Study Limitations
A limitation to this study is the retrospective study
design, although postoperative echocardiography at rest
and exercise was performed in a prospectively organized
setup. The small study sample might have led to type II
statistical errors in our study results. The fact that not all
patients with IMR were able to participate in the study for
various reasons (Figure 1) might have induced some
selection bias. However, when comparing the postoperative
mean transmitral gradient after ICU discharge in the
participating patients (n ¼ 23) versus the nonparticipating
patients (n ¼ 11), no significant difference was observed
(4.8  1.7 mm Hg vs 4.5  1.6 mm Hg, respectively,
P ¼ .85).The Journal of Thoracic and CaCONCLUSIONS
This study demonstrated that a standardized RMA
combined with CABG induces LV remodeling with a
concomitant improvement in functional status and a low
incidence of recurrent IMR. Postoperative transmitral
gradients did not correlate with functional capacity as
measured by VO2max. However, functional capacity and
transmitral gradients seem determined not only by the
severity of MS but also by other hemodynamic factors,
such as ejection fraction and cardiac output. For correct
interpretation of transmitral gradients at rest and during
exercise, the hemodynamics of the patient should be taken
into account. In the future, a more hemodynamically
independent parameter, such as mitral valve area, may be
better suited to assess the impact of functional MS after
RMA.
The authors thank the nursing staff of the cardiac ultrasound
laboratory (R. Reyskens, K. Cuyvers, K. Machiels, and L. Jacobs)
for support in the data collection.
References
1. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of
mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg. 1998;115:
381-8.
2. Bax JJ, Braun J, Somer ST, Klautz R, Holman ER, Versteegh MI, et al. Restric-
tive annuloplasty and coronary revascularization in ischemic mitral regurgitation
results in reverse left ventricular remodeling. Circulation. 2004;110:II103-8.
3. Braun J, van de Veire NR, Klautz RJ, Versteegh MI, Holman ER, Westenberg JJ,
et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and
heart failure. Ann Thorac Surg. 2008;85:430-7.
4. Kainuma S, Taniguchi K, Daimon T, Sakaguchi T, Funatsu T, Kondoh H, et al.
Does stringent restrictive annuloplasty for functional mitral regurgitation cause
functional mitral stenosis and pulmonary hypertension? Circulation. 2011;124:
S97-106.
5. Williams ML, Daneshmand MA, Jollis JG, Horton JR, Shaw LK,
Swaminathan M, et al. Mitral gradients and frequency of recurrence of mitral
regurgitation after ring annuloplasty for ischemic mitral regurgitation.
Ann Thorac Surg. 2009;88:1197-201.
6. Magne J, Senechal M, Mathieu P, Dumesnil JG, Dagenais F, Pibarot P.
Restrictive annuloplasty for ischemic mitral regurgitation may induce functional
mitral stenosis. J Am Coll Cardiol. 2008;51:1692-701.
7. Rubino AS, Onorati F, Santarpia G, Achille F, Lorusso R, Santini F, et al. Impact
of increased transmitral gradients after undersized annuloplasty for chronic
ischemic mitral regurgitation. Int J Cardiol. 2012;158:71-7.
8. Martin CE, Castano M, Gomez-Plana J, Gualis J, Comendador JM, Iglesias I.
Mitral stenosis after IMR ETlogix ring annuloplasty for ischemic regurgitation.
Asian Cardiovasc Thorac Ann. 2012;20:534-8.
9. Pepi M, Tamborini G, Galli C, Barbier P, Doria E, Berti M, et al. A new formula
for echo-Doppler estimation of right ventricular systolic pressure. J Am Soc
Echocardiogr. 1994;7:20-6.
10. Kubota K, Otsuji Y, Ueno T, Koriyama C, Levine RA, Sakata R, et al. Functional
mitral stenosis after surgical annuloplasty for ischemic mitral regurgitation:
importance of subvalvular tethering in the mechanism and dynamic deterioration
during exertion. J Thorac Cardiovasc Surg. 2010;140:617-23.rdiovascular Surgery c Volume 148, Number 1 187
